Clinical Trials Browser

Phase 2 × Breast Neoplasms × pegfilgrastim × Clear all

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03639948 2024-04-11

NeoPACT

Phase 2 Active not recruiting

120 enrolled 12 charts

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00679029 2023-12-11

Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer

Phase 2 Terminated

15 enrolled 9 charts

Breast

Breast Neoplasms

NCT00146562 2023-08-02

Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer

Phase 2 Completed

135 enrolled

Breast

Breast Neoplasms

NCT01847001 2021-09-10

Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Phase 2 Completed

10 enrolled 12 charts

Breast

Breast Neoplasms

NCT02685111 2020-07-31

Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)

Phase 2 Terminated

22 enrolled

BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT01671319 2019-11-27

ddTC

Phase 2 Completed

42 enrolled 12 charts

Breast

Breast Neoplasms

NCT00394251 2019-11-25

Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer

Phase 2 Completed

197 enrolled 23 charts

Breast

Breast Neoplasms

NCT01416389 2019-09-18

A Study of LY2523355 in Participants With Breast Cancer

Phase 2 Completed

39 enrolled 16 charts

Breast

Breast Neoplasms, Neoplasms, Recurrence

NCT01648322 2018-10-03

Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Phase 2 Completed

232 enrolled 19 charts

Breast

Breast Neoplasms, Neutropenia

NCT03575520 2018-07-02

Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients

Phase 2 Completed

63 enrolled

Breast

Breast Neoplasms

NCT01712009 2018-01-30

NOLAN

Phase 2 Completed

600 enrolled 15 charts

Breast

Breast Neoplasms

NCT00404066 2017-12-22

Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer

Phase 2 Completed

21 enrolled 11 charts

Breast

Breast Neoplasms

NCT01498588 2016-10-03

Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer

Phase 2 Terminated

7 enrolled 7 charts

Breast

Breast Neoplasms

NCT00107510 2016-07-06

Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer

Phase 2 Completed

58 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00256360 2014-12-09

Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer

Phase 2 Completed

117 enrolled

Breast

Breast Neoplasms

NCT00119262 2014-05-15

Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer

Phase 2 Completed

226 enrolled 8 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00777673 2013-01-04

Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.

Phase 2 Unknown

60 enrolled

Breast

Breast Neoplasms

NCT00124111 2010-02-26

A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer

Phase 2 Completed

Breast

Breast Neoplasms, Neoplasms, Neutropenia

NCT00261313 2010-02-26

ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer

Phase 2 Completed

80 enrolled

Breast

Breast Neoplasms

NCT00115414 2008-08-01

Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)

Phase 2 Completed

Breast

Breast Neoplasms, Fever, Neutropenia

Clinical Trials

Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer

NeoPACT

Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer

Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer

Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)

ddTC

Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer

A Study of LY2523355 in Participants With Breast Cancer

Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients

NOLAN

Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer

Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer

Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer

Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer

Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer

Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.

A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer

ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer

Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)